The Valley Desk

NCT04809467 · Interventional trial

A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL)

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov